With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs

With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs.
Source: Justin Sullivan/Getty Images

SAN FRANCISCO — When pet dogs are diagnosed with cancer, they typically get surgery, chemotherapy, or radiation — that is, of course, if their owner opts to treat it.

Now, a Silicon Valley startup wants to offer precision medicine instead — by recommending targeted therapies that are normally used to treat humans. For a price tag in the low four figures, depending on the veterinary clinic, the One Health Company will sequence a dog’s tumor and generate a report with recommendations.

The pitch is attracting some high-profile interest here in the Bay Area, where it’s not unusual for dog owners to spend tens of thousands of dollars to try to keep their beloved pet alive. The company that it had raised $5 million in seed funding from top Silicon Valley investors, including the and the startup accelerator .

You're reading a preview, sign up to read more.

More from STAT

STAT7 min readPolitics
Inhumane Or Unavoidable? As Congress Scrutinizes An Increase In Monkey Research, Scientists Defend Its Necessity
Scientists are relying on monkey research more than ever before. And now Congress wants the NIH and FDA to explain why.
STAT3 min readPolitics
With Eyes On Gilead, Lawmakers Want Details On How HHS Reviews Possible Patent Infringement
After a ruckus over a pricey Gilead Sciences drug for HIV, lawmakers want details on how HHS reviews possible patent infringement.
STAT2 min readScience
Pfizer Spends $11.4 Billion To Buy Array BioPharma For Its Cancer Drug Chemistry
Pfizer said it will spend $11.4 billion in cash to purchase Array BioPharma, a Boulder, Colo.-based biotech known as a top choice among biotechnology firms that need to synthesize new…